OpenAI Invests in Startup That Uses Brain Implants to Detect Cancer (www.wired.com)

OpenAI has invested in Coherence, a startup aiming to harness brain-computer interface technology for cancer detection. This investment is part of a $45 million seed funding round and highlights the increasing intersection between AI and brain data. Coherence’s CEO, Ben Woodington, emphasizes the potential for AI to analyze vast neural datasets produced by their devices, allowing for innovative approaches in healthcare, particularly in optimizing cancer treatments. Coherence’s technology focuses on detecting subtle electrical signals associated with brain tumors and aims to facilitate real-time treatment through advanced AI models. The company has already conducted initial tests on three patients during brain tumor surgeries and plans to expand testing with a long-term clinical trial for glioblastoma patients. Notably, the implant not only identifies tumor signals but also delivers mild electrical stimulation to potentially halt tumor growth. OpenAI’s involvement underscores its commitment to leveraging novel data sources for groundbreaking healthcare applications, while Coherence assures that its data will remain confidential and separate from OpenAI’s other initiatives.